Cargando…
PM(2.5) and cardiovascular diseases: State-of-the-Art review
Air pollution, especially exposure to particulate matter 2.5 (PM(2.5)), has been associated with an increase in morbidity and mortality around the world. Specifically, it seems that PM(2.5) promotes the development of cardiovascular risk factors such as hypertension and atherosclerosis, while being...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585625/ https://www.ncbi.nlm.nih.gov/pubmed/37869561 http://dx.doi.org/10.1016/j.ijcrp.2023.200217 |
_version_ | 1785122992569712640 |
---|---|
author | Krittanawong, Chayakrit Qadeer, Yusuf Kamran Hayes, Richard B. Wang, Zhen Thurston, George D. Virani, Salim Lavie, Carl J. |
author_facet | Krittanawong, Chayakrit Qadeer, Yusuf Kamran Hayes, Richard B. Wang, Zhen Thurston, George D. Virani, Salim Lavie, Carl J. |
author_sort | Krittanawong, Chayakrit |
collection | PubMed |
description | Air pollution, especially exposure to particulate matter 2.5 (PM(2.5)), has been associated with an increase in morbidity and mortality around the world. Specifically, it seems that PM(2.5) promotes the development of cardiovascular risk factors such as hypertension and atherosclerosis, while being associated with an increased risk of cardiovascular diseases, including myocardial infarction (MI), stroke, heart failure, and arrhythmias. In this review, we seek to elucidate the pathophysiological mechanisms by which exposure to PM(2.5) can result in adverse cardiovascular outcomes, in addition to understanding the link between exposure to PM(2.5) and cardiovascular events. It is hypothesized that PM(2.5) functions via 3 mechanisms: increased oxidative stress, activation of the inflammatory pathway of the immune system, and stimulation of the autonomic nervous system which ultimately promote endothelial dysfunction, atherosclerosis, and systemic inflammation that can thus lead to cardiovascular events. It is important to note that the various cardiovascular associations of PM(2.5) differ regarding the duration of exposure (short vs long) to PM(2.5), the source of PM(2.5), and regulations regarding air pollution in the area where PM(2.5) is prominent. Current strategies to reduce PM(2.5) exposure include personal strategies such as avoiding high PM(2.5) areas such as highways or wearing masks outdoors, to governmental policies restricting the amount of PM(2.5) produced by organizations. This review, by highlighting the significant impact between PM(2.5) exposure and cardiovascular health will hopefully bring awareness and produce significant change regarding dealing with PM(2.5) levels worldwide. |
format | Online Article Text |
id | pubmed-10585625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105856252023-10-20 PM(2.5) and cardiovascular diseases: State-of-the-Art review Krittanawong, Chayakrit Qadeer, Yusuf Kamran Hayes, Richard B. Wang, Zhen Thurston, George D. Virani, Salim Lavie, Carl J. Int J Cardiol Cardiovasc Risk Prev Review Article Air pollution, especially exposure to particulate matter 2.5 (PM(2.5)), has been associated with an increase in morbidity and mortality around the world. Specifically, it seems that PM(2.5) promotes the development of cardiovascular risk factors such as hypertension and atherosclerosis, while being associated with an increased risk of cardiovascular diseases, including myocardial infarction (MI), stroke, heart failure, and arrhythmias. In this review, we seek to elucidate the pathophysiological mechanisms by which exposure to PM(2.5) can result in adverse cardiovascular outcomes, in addition to understanding the link between exposure to PM(2.5) and cardiovascular events. It is hypothesized that PM(2.5) functions via 3 mechanisms: increased oxidative stress, activation of the inflammatory pathway of the immune system, and stimulation of the autonomic nervous system which ultimately promote endothelial dysfunction, atherosclerosis, and systemic inflammation that can thus lead to cardiovascular events. It is important to note that the various cardiovascular associations of PM(2.5) differ regarding the duration of exposure (short vs long) to PM(2.5), the source of PM(2.5), and regulations regarding air pollution in the area where PM(2.5) is prominent. Current strategies to reduce PM(2.5) exposure include personal strategies such as avoiding high PM(2.5) areas such as highways or wearing masks outdoors, to governmental policies restricting the amount of PM(2.5) produced by organizations. This review, by highlighting the significant impact between PM(2.5) exposure and cardiovascular health will hopefully bring awareness and produce significant change regarding dealing with PM(2.5) levels worldwide. Elsevier 2023-10-12 /pmc/articles/PMC10585625/ /pubmed/37869561 http://dx.doi.org/10.1016/j.ijcrp.2023.200217 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Krittanawong, Chayakrit Qadeer, Yusuf Kamran Hayes, Richard B. Wang, Zhen Thurston, George D. Virani, Salim Lavie, Carl J. PM(2.5) and cardiovascular diseases: State-of-the-Art review |
title | PM(2.5) and cardiovascular diseases: State-of-the-Art review |
title_full | PM(2.5) and cardiovascular diseases: State-of-the-Art review |
title_fullStr | PM(2.5) and cardiovascular diseases: State-of-the-Art review |
title_full_unstemmed | PM(2.5) and cardiovascular diseases: State-of-the-Art review |
title_short | PM(2.5) and cardiovascular diseases: State-of-the-Art review |
title_sort | pm(2.5) and cardiovascular diseases: state-of-the-art review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585625/ https://www.ncbi.nlm.nih.gov/pubmed/37869561 http://dx.doi.org/10.1016/j.ijcrp.2023.200217 |
work_keys_str_mv | AT krittanawongchayakrit pm25andcardiovasculardiseasesstateoftheartreview AT qadeeryusufkamran pm25andcardiovasculardiseasesstateoftheartreview AT hayesrichardb pm25andcardiovasculardiseasesstateoftheartreview AT wangzhen pm25andcardiovasculardiseasesstateoftheartreview AT thurstongeorged pm25andcardiovasculardiseasesstateoftheartreview AT viranisalim pm25andcardiovasculardiseasesstateoftheartreview AT laviecarlj pm25andcardiovasculardiseasesstateoftheartreview |